Abstract
Objective
To perform a systematic review and meta-analysis comparing two pre-operative transfusion regimens (conservative versus aggressive) in children with sickle cell disease(SCD) undergoing adenotonsillectomy in terms of post-operative complications, complications related to SCD and transfusion related complications.
Data Sources and Review Methods
A literature review was performed through PubMed, EMBASE, Cochrane, and Ovid databases using the following phrases: (Adenotonsillectomy OR Tonsillectomy) AND (Sickle Cell Disease OR Sickle Cell Trait). Using predetermined inclusion and exclusion criteria, seven articles were selected for systemic review and two control trials were included in meta-analysis.
Results
Out of a total of 3,146 results, seven articles were selected for review and two controlled trials were included in the meta-analysis. There was no statistically significant difference in the rate of primary and secondary hemorrhage between the aggressive and conservative transfusion regimens (RR = 3.1, CI = 0.84–11.4, p-value = 0.089). The rate of sickle cell disease related complications including vaso-occlusive crisis and acute chest syndrome was also not statistically significant between the two transfusion groups (RR = 1.4, CI = 0.7–2.8, p-value = 0.339). Even though, the transfusion related complications did not reach statistical significance, there was a higher complication rate in the group receiving aggressive blood transfusion.
Conclusion
In SCD children undergoing adenotonsillectomy, an aggressive transfusion regimen that focuses on reducing the Hemoglobin S ratio to below 30% has not been shown to be more effective in reducing post-operative complications when compared to a conservative transfusion regimen. Therefore, it is reasonable to utilize a conservative transfusion regimen, thereby reducing the transfusion-associated risks.
Similar content being viewed by others
References
Duke RL, Scott JP, Panepinto JA, Flanary VA (2006) Perioperative management of sickle cell disease children undergoing adenotonsillectomy. Otolaryngol Head Neck Surg 134:370–373
Griffin TC, Buchanan GR. Elective Surgery in Children with Sickle Cell Disease Without Preoperative Blood Transfusion(1993).J Pediatr. 28:681–685
Halvorson DJ, McKie V, McKie K et al (1997) Sickle Cell Disease and Tonsillectomy. Arch Otolaryngol Head Neck Surg 123:689–692
Vichinsky EP, Haberkern CM, Neumayr L et al (1995) A Comparison of Conservative and Aggressive Transfusion Regimens in the Perioperative Management of Sickle Cell Disease. N Engl J Med 333:206–213
Coker N, Milner P (1982) Elective Surgery in Patients with Sickle Cell Anemia. Arch Otolaryngol 108:574–576
Howard J, Malfroy M, Llewelyn C et al (2013) The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomized,controlled, multicenter clinical trial. Lancet 381:930–938
Waldron P, Pegelow C, Neumayr L et al (1999) Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. Preoperative Transfusion is Sickle Cell Disease Study Group. J Pediatr Hematol Oncol 21:129–135
Wali YA, al Okbi H, Abri R (2003) A comparison of two transfusion regimens in the perioperative management of children with sickle cell disease undergoing adenotonsillectomy. Pediatr Hematol Oncol 20:7–13
Moher D, Shamseer L, Clarke M, etal (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst reviews 4(1):1
OCEBM Levels of Evidence Working Group (2016) The Oxford Levels of Evidence 2. Oxford Centre for Evidence Based Medicine. https://www.cebm.net/index.aspx?o=5653 (accessed
Al-Jaouni SK, Al-Muhayawi SM, Qari MH et al (2006) Randomized clinical trial to evaluate the safety of avoiding pre-operative transfusion in sickle cell anemia. Bahrain Med Bull 28:164–167
Derkay C, Bray G, Milmoe G et al (1991) Adenotonsillectomy in Children with Sickle Cell Disease. South Med J 84:205–218
Farrell AN, Goudy SL, Yee ME, Leu RM, Landry AM (2018) Adenotonsillectomy in children with sickle cell disease and obstructive sleep apnea. Int J Pediatr Otorhinolaryngol 111:158–161
Atwood CM, Gnagi SH, Teufel IIRJ, Nguyen SA, White DR (2017) Blood transfusion in children with sickle cell disease undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol 103:117–120
Evidence-Based Management of Sickle Cell Disease (2014) :Expert Panel Report, US Department of Health and Human Services
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial Disclosure
No external funding was received in association with this study, and no financial interests are held by any of the authors.
Conflict of Interest
None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kanotra, S., Muller, S.H., Kanotra, J. et al. Preoperative Transfusion in Sickle Cell Disease Children Undergoing Adenotonsillectomy. Indian J Otolaryngol Head Neck Surg 75, 227–235 (2023). https://doi.org/10.1007/s12070-022-03137-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-022-03137-7